Holen Sie sich die Stockscreener-App
0.874
3.49%
-0.029
Handel nachbörslich:
.87
-0.004
-0.46%
Schlusskurs vom Vortag:
$0.903
Offen:
$0.9035
24-Stunden-Volumen:
136.63K
Relative Volume:
0.32
Marktkapitalisierung:
$17.09M
Einnahmen:
$411.00K
Nettoeinkommen (Verlust:
$-4.85M
KGV:
-1.9864
EPS:
-0.44
Netto-Cashflow:
$-4.88M
1W Leistung:
+4.16%
1M Leistung:
-26.76%
6M Leistung:
-38.19%
1J Leistung:
-71.52%
1-Tages-Spanne:
$0.8505
$0.91
1-Wochen-Bereich:
$0.8202
$0.99
52-Wochen-Spanne:
$0.7749
$3.06
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Firmenname
Lexaria Bioscience Corp
Sektor
Branche
Telefon
250-765-6424
Adresse
100 - 740 MCCURDY ROAD, KELOWNA
Vergleichen Sie LEXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
0.874 | 20.07M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lexaria Bioscience Corp Aktie (LEXX) Neueste Nachrichten
Chart based exit strategy for Lexaria Bioscience Corp.2025 Historical Comparison & AI Forecasted Entry/Exit Points - newser.com
Combining machine learning predictions for Lexaria Bioscience Corp. Equity WarrantQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
How to use a screener to detect Lexaria Bioscience Corp. Equity Warrant breakoutsWeekly Profit Summary & Stepwise Trade Execution Plans - newser.com
Can trapped investors hope for a rebound in Lexaria Bioscience Corp. Equity WarrantQuarterly Portfolio Review & High Return Trade Guides - newser.com
Is Lexaria Bioscience Corp. stock ready for a breakoutJuly 2025 Sentiment & Long-Term Safe Investment Plans - newser.com
What catalysts could drive Lexaria Bioscience Corp. stock higherShort Setup & Real-Time Chart Breakout Alerts - newser.com
Price action breakdown for Lexaria Bioscience Corp. Equity WarrantQuarterly Earnings Summary & Weekly Return Optimization Alerts - newser.com
How Lexaria Bioscience Corp. stock performs in rising dollar environmentJuly 2025 Earnings & Reliable Entry Point Alerts - newser.com
Is Lexaria Bioscience Corp. Equity Warrant stock in correction or buying zone2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com
Will Lexaria Bioscience Corp. Equity Warrant outperform the marketTrade Risk Summary & Technical Buy Zone Confirmations - newser.com
Earnings visualization tools for Lexaria Bioscience Corp. Equity Warrant2025 Valuation Update & Safe Capital Growth Tips - newser.com
Can Lexaria Bioscience Corp. hit a new high this monthMarket Risk Analysis & Smart Allocation Stock Reports - newser.com
Lexaria expands pharmaceutical outreach with new advisory firm By Investing.com - Investing.com Nigeria
Lexaria Bioscience Corp. Provides Strategic Update - NewMediaWire
Lexaria Bioscience Expands Strategic Outreach and Secures New Patents - TipRanks
Lexaria (LEXX) Expands R&D Efforts with Enhanced Funding and New Partnerships - GuruFocus
Lexaria expands pharmaceutical outreach with new advisory firm - Investing.com India
$4.0M Financing backs Lexaria's global BD push; 4 new patents bolster DehydraTECH R&D into 2026 - Stock Titan
Can trapped investors hope for a rebound in Lexaria Bioscience Corp.2025 Major Catalysts & Community Verified Swing Trade Signals - newser.com
Historical volatility pattern of Lexaria Bioscience Corp. visualized2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Custom watchlist performance reports with Lexaria Bioscience Corp.2025 Major Catalysts & Pattern Based Trade Signal System - newser.com
News impact scoring models applied to Lexaria Bioscience Corp. Equity WarrantMarket Sentiment Report & Real-Time Volume Analysis - newser.com
Can swing trading help recover from Lexaria Bioscience Corp. Equity Warrant losses2025 Key Lessons & Weekly Top Gainers Alerts - newser.com
Lexaria Bioscience Corp Stock Analysis and ForecastAutomated Trading Signals & Explosive Capital Growth - earlytimes.in
Will Lexaria Bioscience Corp. see short term momentumMarket Sentiment Report & Fast Entry High Yield Stock Tips - newser.com
Lexaria Bioscience Corp. Equity Warrant stock daily chart insightsWeekly Risk Report & High Conviction Trade Alerts - newser.com
Real time social sentiment graph for Lexaria Bioscience Corp.Quarterly Trade Review & Technical Pattern Based Buy Signals - newser.com
Smart tools for monitoring Lexaria Bioscience Corp.’s price actionWeekly Market Outlook & Weekly Stock Performance Updates - newser.com
Can Lexaria Bioscience Corp. Equity Warrant stock deliver surprise earnings beatCPI Data & Fast Moving Trade Plans - newser.com
When is the best time to exit Lexaria Bioscience Corp.Entry Point & Community Verified Trade Signals - newser.com
Is Lexaria Bioscience Corp. stock reversal real or fakeAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
What drives Lexaria Bioscience Corp stock priceFundamental Stock Analysis & High Yield Trading Plans - earlytimes.in
Lexaria Bioscience Corp. Equity Warrant stock trendline breakdownWeekly Stock Summary & Accurate Buy Signal Alerts - newser.com
What’s next for Lexaria Bioscience Corp. Equity Warrant stock price2025 Price Action Summary & Breakout Confirmation Alerts - newser.com
Chart based exit strategy for Lexaria Bioscience Corp. Equity WarrantJuly 2025 Momentum & Free High Return Stock Watch Alerts - newser.com
Will earnings trigger a reversal in Lexaria Bioscience Corp.2025 Stock Rankings & Reliable Trade Execution Plans - newser.com
Finanzdaten der Lexaria Bioscience Corp-Aktie (LEXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):